Honkoop AH - Search Results

1

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy.

Lam SW, Nota NM, Jager A, Bos MM, van den Bosch J, van der Velden AM, Portielje JE, Honkoop AH, van Tinteren H, Boven E; ATX Trial Team. Lam SW, et al. Among authors: honkoop ah. Clin Cancer Res. 2016 Apr 1;22(7):1611-20. doi: 10.1158/1078-0432.CCR-15-1005. Epub 2016 Jan 28. Clin Cancer Res. 2016. PMID: 26823602

2

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.

Linn SC, Honkoop AH, Hoekman K, van der Valk P, Pinedo HM, Giaccone G. Linn SC, et al. Among authors: honkoop ah. Br J Cancer. 1996 Jul;74(1):63-8. doi: 10.1038/bjc.1996.316. Br J Cancer. 1996. PMID: 8679460 Free PMC article.

3

Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

Honkoop AH, Hoekman K, Wagstaff J, van Groeningen CJ, Vermorken JB, Boven E, Pinedo HM. Honkoop AH, et al. Br J Cancer. 1996 Oct;74(7):1132-6. doi: 10.1038/bjc.1996.502. Br J Cancer. 1996. PMID: 8855987 Free PMC article. Clinical Trial.

4

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer.

Honkoop AH, Pinedo HM, De Jong JS, Verheul HM, Linn SC, Hoekman K, Wagstaff J, van Diest PJ. Honkoop AH, et al. Am J Clin Pathol. 1997 Feb;107(2):211-8. doi: 10.1093/ajcp/107.2.211. Am J Clin Pathol. 1997. PMID: 9024070

5

Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients.

Honkoop AH, Hoekman K, Wagstaff J, Boven E, van Groeningen CJ, Giaccone G, Vermorken JB, Pinedo HM. Honkoop AH, et al. Ann Oncol. 1996 Jan;7(1):35-9. doi: 10.1093/oxfordjournals.annonc.a010474. Ann Oncol. 1996. PMID: 9081389 Free article.

6

Expression of drug resistance proteins in breast cancer, in relation to chemotherapy.

Linn SC, Pinedo HM, van Ark-Otte J, van der Valk P, Hoekman K, Honkoop AH, Vermorken JB, Giaccone G. Linn SC, et al. Among authors: honkoop ah. Int J Cancer. 1997 May 29;71(5):787-95. doi: 10.1002/(sici)1097-0215(19970529)71:5<787::aid-ijc16>3.0.co;2-5. Int J Cancer. 1997. PMID: 9180147 Free article.

7

Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer.

Honkoop AH, van der Wall E, Feller N, Schuurhuis GJ, van der Vijgh WJ, Boven E, van Groeningen CJ, Giaccone G, Hoekman K, Vermorken JB, Wagstaff J, Pinedo HM. Honkoop AH, et al. Ann Oncol. 1997 Oct;8(10):957-62. doi: 10.1023/a:1008259518263. Ann Oncol. 1997. PMID: 9402167 Free article.

8

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.

Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM. Honkoop AH, et al. Br J Cancer. 1998 Feb;77(4):621-6. doi: 10.1038/bjc.1998.99. Br J Cancer. 1998. PMID: 9484820 Free PMC article.

9

Management of stage III breast cancer.

Honkoop AH, Wagstaff J, Pinedo HM. Honkoop AH, et al. Oncology. 1998 May-Jun;55(3):218-27. doi: 10.1159/000011861. Oncology. 1998. PMID: 9560054 Review.

10

Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer.

Honkoop AH, Luykx-de Bakker SA, Hoekman K, Meyer S, Meyer OW, van Groeningen CJ, van Diest PJ, Boven E, van der Wall E, Giaccone G, Wagstaff J, Pinedo HM. Honkoop AH, et al. Oncologist. 1999;4(2):106-11. Oncologist. 1999. PMID: 10337380 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page